![](/img/cover-not-exists.png)
Inhibition of the CCL2 receptor, CCR2, enhances tumor response to immune checkpoint therapy
Tu, Megan M., Abdel-Hafiz, Hany A., Jones, Robert T., Jean, Annie, Hoff, Katelyn J., Duex, Jason E., Chauca-Diaz, Ana, Costello, James C., Dancik, Garrett M., Tamburini, Beth A. Jirón, Czerniak, BogdVolume:
3
Journal:
Communications Biology
DOI:
10.1038/s42003-020-01441-y
Date:
December, 2020
File:
PDF, 1.40 MB
2020